GARFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--AxioMed® Spine Corporation, a development stage medical company with innovative spinal implants to restore the native motion of the spine, announces the addition of Neal Defibaugh as Vice President for Clinical and Regulatory affairs. He joins AxioMed during the development of the Freedom™ Lumbar Disc (FLD) System, the next generation of total disc replacement and first implant system in the Company’s pipeline. AxioMed’s goal is to establish clinical and economic value of this pioneering technology through rigorous, well planned clinical studies in the United States and Europe. The Company’s mission is to restore the native function of the spine through its total disc replacement technology for the lumbar and cervical spine.
